Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors

European Journal of Pharmacology

Volumn 427, Issue 3, 2001, Pages 187-193

  Lidow, Michael S ^a   Roberts, Amy ^a   Zhang, Ling ^a   Koh, Phil Ok ^a   Lezcano, Nelson ^b   Bergson, Clare ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Affinity; Agonist; Antagonist; G protein; Receptor binding assay; Receptor crosstalk

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; CALCIUM ION; CALCYON; CARBACHOL; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATE; MUSCARINIC RECEPTOR; PROPYLNORAPOMORPHINE; PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; APOMORPHINE; BINDING, COMPETITIVE; CARBACHOL; CELL LINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANOSINE TRIPHOSPHATE; HUMANS; MEMBRANE PROTEINS; RADIOLIGAND ASSAY; RECEPTOR CROSS-TALK; RECEPTORS, DOPAMINE D1; TRITIUM;

EID: 0035929134     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01265-1     Document Type: Article

References (25)

1. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity
2. Receptor-effector coupling by G proteins
3. BW373U86: A nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells
4. 3H-N-n-propylnorapomorphine: A novel agonist ligand for central dopamine receptors
5. D1 dopamine receptors in human putamen, frontal cortex and calf retina: Differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation
6. 1-coupled and uncoupled states
7. Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes
8. Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity
9. Heptahelical receptor signaling: Beyond the G protein paradigm
10. The many faces of G protein signaling
11. Characterization of radiolabeled agonist binding to β-adrenergic receptors in mammalian tissues
12. 3H]SCH23390-labeled D1 dopamine receptors in rat striatum
13. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines
14. A quantitative analysis of beta-adrenergic receptor interactions: Resolution of high and low affinity states of the receptor by computer modeling of ligand binding data
15. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein
16. SH3 binding domains in the dopamine D4 receptor
17. Constitutive activation of a single effector pathway: Evidence for multiple activation states of G protein-coupled receptor
18. High affinity agonist binding is not sufficient for agonist efficacy at 5-hydrohytriptamine-2A receptors: Evidence in favor of a modified ternary complex model
19. 3H]SCH23390 in rat brain: Regional distribution and effects of assay conditions and GTP
20. 2-adrenoreceptor-mediated signaling
21. 3H-N-propylnorapomorphine
22. Affinity shift induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors
23. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide 1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide 1 receptors: Evidence for multiple receptor states
24. Kinetics versus equilibrium: The importance of GTP in GPCR activation
25. 7 subunit suggests a role in hormone regulation of adenylyl cyclase activity